Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-027467
Filing Date
2017-11-27
Accepted
2017-11-27 19:42:54
Documents
1
Period of Report
2017-11-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4026
  Complete submission text file 0000899243-17-027467.txt   5487
Mailing Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005
Business Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005 646-205-1603
TYME TECHNOLOGIES, INC. (Issuer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005
Business Address
Biehl James (Reporting) CIK: 0001710484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38169 | Film No.: 171223942